drugset / Trial / NCT04624867
Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch
NaSingle-groupOpen-labelOther
Summary
A randomized, evaluator-blinded study to assess skin irritation and skin sensitization of HP-1050 transdermal system (HP-1050) in comparison to XULANE patch in healthy female volunteers.
Timeline
- Start
- 2020-11-03
- Primary completion
- 2022-01-31
- Completion
- 2022-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HP-1050 | Unknown | — | Other |
| Subject | Transdermal Contraceptive | Unknown | — | Other |
Indications
No indication recorded.